Overview

Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study will determine the safety and effectiveness of escitalopram (Lexapro)in treating obsessive-compulsive disorder (OCD) symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Duke University
Collaborator:
Forest Laboratories
Treatments:
Citalopram
Dexetimide